Cargando…

Lymphocyte-polarized DC1s: Effective inducers of tumor-specific CTLs

Activated lymphocytes secrete dendritic cell (DC)-activating cytokines including tumor necrosis factor α and interferon γ, and induce Type-1-polarized DCs (DC1s). Lymphocyte-polarized DC1s secrete high levels of biologically active interleukin-12 (IL-12p70) and CXCL10 and show enhanced CTL-inducing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berk, Erik, Kalinski, Pawel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518532/ https://www.ncbi.nlm.nih.gov/pubmed/23243623 http://dx.doi.org/10.4161/onci.21295

Ejemplares similares

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells
por: Kiessling, Rolf, et al.
Publicado: (2012)

CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity: a few T cells can influence the growth of many times more tumor cells
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

Virus infections in tumors pave the way for tumor-directed DC-vaccines
por: Woller, Norman, et al.
Publicado: (2012)

The antigen specific composition of melanoma tumor infiltrating lymphocytes?
por: Hadrup, Sine Reker
Publicado: (2012)

Key role of the positive feedback between PGE(2) and COX2 in the biology of myeloid-derived suppressor cells
por: Obermajer, Nataŝa, et al.
Publicado: (2012)

Regulation of DC development and DC-mediated T-cell immunity via CISH
por: Miah, Mohammad Alam, et al.
Publicado: (2013)

Molecular Imaging in Tracking Tumor-Specific Cytotoxic T Lymphocytes (CTLs)
por: Liu, Zhiyi, et al.
Publicado: (2014)

DC vaccine generated by ALA-PDT-induced immunogenic apoptotic cells for skin squamous cell carcinoma
por: Ji, Jie, et al.
Publicado: (2015)

Radiation-induced tumor dormancy reflects an equilibrium between the proliferation and T lymphocyte-mediated death of malignant cells
por: Liang, Hua, et al.
Publicado: (2013)

Sarcoma response to targeted therapy dynamically polarizes tumor-associated macrophages
por: Cavnar, Michael J, et al.
Publicado: (2014)

Won’t you come on in? How to favor lymphocyte infiltration in tumors
por: Bellone, Matteo, et al.
Publicado: (2012)

Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes
por: Dieli, Francesco, et al.
Publicado: (2013)

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
por: Loi, Sherene
Publicado: (2013)

PD-L1 expression and tumor-infiltrating lymphocytes: Revisiting the antitumor immune response potential in breast cancer
por: Schalper, Kurt A
Publicado: (2014)

The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy
por: Talebian, Fatemeh, et al.
Publicado: (2012)

Dendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cells
por: Berk, Erik, et al.
Publicado: (2014)

Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines
por: García-Vallejo, Juan J., et al.
Publicado: (2013)

Tumor-infiltrating lymphocytes in breast cancer: A new predictor for responses to therapy
por: Issa-Nummer, Yasmin, et al.
Publicado: (2014)

Replenish the source within: Rescuing tumor-infiltrating lymphocytes by double checkpoint blockade
por: Duraiswamy, Jaikumar, et al.
Publicado: (2013)

Sugars boost exhausted tumor-infiltrating lymphocytes by counteracting immunosuppressive activities of galectins
por: Gordon-Alonso, Monica, et al.
Publicado: (2014)

Continuous 4–1BB co-stimulatory signals for the optimal expansion of tumor-infiltrating lymphocytes for adoptive T-cell therapy
por: Chacon, Jessica Ann, et al.
Publicado: (2013)

Overcoming HLA restriction in clinical trials: Immune monitoring of mRNA-loaded DC therapy
por: Van Nuffel, An M.T., et al.
Publicado: (2012)

Tumor-infiltrating lymphocytes and outcome in Merkel cell carcinoma, a virus-associated cancer
por: Sihto, Harri, et al.
Publicado: (2012)

Recruitment of γδ T lymphocytes to tumors: A new role for the pleiotropic chemokine CCL2
por: Lança, Telma, et al.
Publicado: (2013)

Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer
por: Martinet, Ludovic, et al.
Publicado: (2012)

Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis
por: Lizotte, Patrick H, et al.
Publicado: (2014)

The emergence of WT1-specific T-cell responses following allogeneic T cell-depleted hematopoietic stem cell transplantation and low-dose donor lymphocyte infusions is associated with a graft-vs.- myeloma effect
por: Tyler, Eleanor M, et al.
Publicado: (2013)

Early predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy
por: Wimmers, Florian, et al.
Publicado: (2014)

Radiotherapy supports protective tumor-specific immunity
por: Gupta, Anurag, et al.
Publicado: (2012)

Tumor suppressors control ULBP2, an innate surface ligand of the lymphocyte immune receptor NKG2D
por: Heinemann, Anja, et al.
Publicado: (2012)

Nfkb1 suppresses DNA alkylation-induced tumor formation
por: Schmitt, Adam M, et al.
Publicado: (2015)

Characterization of the human tumor microbiome reveals tumor-type specific intra-cellular bacteria
por: Livyatan, Ilana, et al.
Publicado: (2020)

Tumor infiltration by chemokine receptor 7 (CCR7)(+) T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer
por: Correale, Pierpaolo, et al.
Publicado: (2012)

Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer
por: Webb, John R, et al.
Publicado: (2014)

Regulation of tumor-associated high-endothelial venules by dendritic cells: A new opportunity to promote lymphocyte infiltration into breast cancer?
por: Martinet, Ludovic, et al.
Publicado: (2013)

Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis
por: Bastid, Jérémy, et al.
Publicado: (2014)

HEPA and PARSE: Systematic discovery of clinically relevant tumor-specific antigens
por: Xu, Qing-Wen, et al.
Publicado: (2013)

Cytotoxic T lymphocytes: Sniping cancer stem cells
por: Hirohashi, Yoshihiko, et al.
Publicado: (2012)

How quantitative differences in dendritic cell maturation can direct T(H)1/T(H)2-cell polarization
por: Lutz, Manfred B.
Publicado: (2013)

Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy
por: Tsuji, Takemasa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0q56ivhsnkqhr970gakik2dbtt